Search

Your search keyword '"Scarabelli, Marilena"' showing total 22 results
Start Over Author "Scarabelli, Marilena"
22 results on '"Scarabelli, Marilena"'

1. Comparison of Complications and Outcomes to One Year of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis

Author

Tamburino, Corrado, Barbanti, Marco, Capodanno, Davide, Mignosa, Carmelo, Gentile, Maurizio, Aruta, Patrizia, Pistritto, Anna Maria, Bonanno, Claudio, Bonura, Salvatore, Cadoni, Alessandra, Gulino, Simona, Di Pasqua, Maria Concetta, Cammalleri, Valeria, Scarabelli, Marilena, Mulè, Massimiliano, Immè, Sebastiano, Del Campo, Giuliana, and Ussia, Gian Paolo

Published
2012
Full Text
View/download PDF

18. Quality of life following percutaneous mitral valve repair with the MitraClip System

Author

Ussia, Gian Paolo, primary, Cammalleri, Valeria, additional, Sarkar, Kunal, additional, Scandura, Salvatore, additional, Imm, Sebastiano, additional, Pistritto, Anna Maria, additional, Caggegi, Anna, additional, Chiarand, Marta, additional, Mangiafico, Sarah, additional, Barbanti, Marco, additional, Scarabelli, Marilena, additional, Mul, Massimiliano, additional, Aruta, Patrizia, additional, and Tamburino, Corrado, additional

Published
2012
Full Text
View/download PDF

19. Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up

Author

Ussia, Gian Paolo, primary, Barbanti, Marco, additional, Sarkar, Kunal, additional, Aruta, Patrizia, additional, Scarabelli, Marilena, additional, Cammalleri, Valeria, additional, Immè, Sebastiano, additional, Pistritto, Anna Maria, additional, Gulino, Simona, additional, Mulè, Massimiliano, additional, Deste, Wanda, additional, Cannata, Stefano, additional, and Tamburino, Corrado, additional

Published
2012
Full Text
View/download PDF

20. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis

Author

Ussia, Gian, primary, Barbanti, Marco, additional, Cammalleri, Valeria, additional, Scarabelli, Marilena, additional, Mulè, Massimiliano, additional, Aruta, Patrizia, additional, Pistritto, Anna Maria, additional, Immè, Sebastiano, additional, Capodanno, Davide, additional, Sarkar, Kunal, additional, Gulino, Simona, additional, and Tamburino, Corrado, additional

Published
2011
Full Text
View/download PDF

21. Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation.

Author

Ussia GP, Capodanno D, Barbanti M, Scarabelli M, Imme S, Cammalleri V, Mule M, Pistritto A, Aruta P, and Tamburino C

Subjects
Aged, Aged, 80 and over, Blood Pressure, Feasibility Studies, Female, Humans, Male, Preoperative Care, Risk Factors, Treatment Outcome, Angioplasty, Aortic Valve Stenosis surgery, Catheterization, Heart Valve Prosthesis Implantation, Palliative Care
Abstract

Objectives: To provide data on feasibility, safety and efficacy of balloon aortic valvuloplasty (BAV) as a bridge to transcatheter aortic valve implantation (TAVI). Background. There are no data on BAV use as a bridge to TAVI in patients at high risk of periprocedural complications., Methods: Between June 2007 to May 2009, 83 consecutive patients with symptomatic severe aortic stenosis (48 female, 35 male) aged from 65 to 88 years (mean age 81 +/- 5 years) were treated with TAVI. Early hemodynamic and clinical outcomes of patients undergoing palliative BAV before TAVI (BAV Group, n = 43) were compared with those of patients who directly underwent TAVI (no-BAV Group, n = 40)., Results: Patients in the BAV group had worse baseline clinical characteristics than those in the no-BAV group, with higher rates of congestive heart failure, New York Heart Association (NYHA) functional class III or IV and a higher EuroSCORE. In the BAV group, significant changes were found after valvuloplasty with regard to NYHA functional class, mean pressure gradient and aortic valve area. Peak-to-peak transvalvular pressure gradient and left ventricular systolic pressure also decreased immediately after BAV. Before TAVI, no differences in either clinical status or hemodynamic data were observed between patients who underwent BAV and those who did not., Conclusions: Bridging to TAVI with BAV is a feasible and reasonably safe approach to offer temporary relief in selected high-risk patients with symptomatic severe aortic stenosis and a high chance of periprocedural complications.

Published
2010

22. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis.

Author

Tamburino C, Capodanno D, Mulè M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, and Ussia G

Subjects
Aged, Aged, 80 and over, Aortic Valve diagnostic imaging, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis physiopathology, Echocardiography, Female, Follow-Up Studies, Heart Valve Prosthesis Implantation adverse effects, Humans, Male, Prospective Studies, Risk Factors, Severity of Illness Index, Stroke Volume physiology, Treatment Outcome, Aortic Valve surgery, Aortic Valve Stenosis surgery, Heart Valve Prosthesis adverse effects, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation methods, Outcome Assessment, Health Care
Abstract

Background: Percutaneous aortic valve replacement (PAVR) is an emerging alternative for high-risk patients with severe aortic stenosis. The aim of this study was to report acute and short-term outcomes of PAVR with the 18 Fr CoreValve Revalving System., Methods: From January 2007 to July 2008, 69 high-risk symptomatic patients with severe aortic stenosis were screened to assess their eligibility criteria for PAVR. All candidates were evaluated by a cardiac surgeon and a cardiologist. Thirty patients (13 men, 17 women, ages 82 +/- 5 years, range 73-88 years) met all the eligibility criteria and were enrolled in the study., Results: Twenty-nine patients (97%) underwent successful valve implantation by a retrograde approach, with improvement in valve area (0.61 +/- 0.18 cm(2) to 1.49 +/- 0.39 cm(2); p < 0.001) and transvalvular gradient (58.1 +/- 17.6 mmHg to 9.2 +/- 4.0; p < 0.001). Paravalvular leakages were 1+ (n = 12) and 2+ (n = 2). Procedural success was achieved in 93% of patients, with 1 case of pericardial tamponade occurred during the first 48 hours after implantation. At 30-day mortality was 7%. The mean NYHA Functional Class declined from 2.72 +/- 0.59 to 1.31 +/- 0.47 (p < 0.001). No other major adverse events occurred at a mean follow up of 4.9 +/- 4.0 months (range 1-13 months)., Conclusions: Our initial experience of PAVR in a cohort of older and high-risk surgical patients has been positive, with excellent acute and encouraging short-term results in terms of safety and efficacy.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results